Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Posts Sharp Jump in Q3 Revenue as Expenses Plummet

NEW YORK, Oct. 23 (GenomeWeb News) - Third Wave Technologies today reported a substantial jump in total revenue atop an increase in R&D spending and a substantially narrowed net loss.

 

Total receipts for the three months ended Sept. 30 jumped to $9.4 million from $5 million one year ago. Product revenue made up the bulk of that growth, generating $9 million in the current third quarter compared with $4.6 million year over year.

 

R&D spending, meantime, inched up to $2.8 million from $2.6 million during the third quarter last year, Third Wave said. However, because of Third Wave's ongoing cost-cutting strategy, total expenses for the third quarter fell to $10.5 million from $31.7 million one year ago.

 

The third-quarter revenue, the costs savings, plus a restructuring charge in the third quarter last year, caused net loss in the current third quarter to fall to $1.4 million, or $.04 per share, from $26.9 million, or $.68 per share, year over year.

 

Third Wave said it had around $60 million in cash, cash equivalents, and short-term investments as of Sept. 30.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.